These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 62857

  • 1. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T, Mizuguchi Y, Suga K.
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract] [Full Text] [Related]

  • 2. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M, Mizuno S.
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [Abstract] [Full Text] [Related]

  • 3. [Drug resistance in Mycobacteria (author's transl)].
    Yamada T, Masuda K.
    Kekkaku; 1976 Oct; 51(10):399-406. PubMed ID: 64637
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK, Kanes W, Davidson PT, Moulding TS.
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes.
    Yamada T, Teshima T, Shiba T.
    Antimicrob Agents Chemother; 1981 Dec; 20(6):834-6. PubMed ID: 6173016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M.
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T, Fukuhara Y.
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis.
    Mizuguchi Y, Suga K, Yamada T.
    Microbiol Immunol; 1979 Apr; 23(7):595-604. PubMed ID: 228161
    [Abstract] [Full Text] [Related]

  • 14. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
    Akbergenov R, Shcherbakov D, Matt T, Duscha S, Meyer M, Wilson DN, Böttger EC.
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4712-7. PubMed ID: 21768509
    [Abstract] [Full Text] [Related]

  • 15. Genetic and biochemical studies on drug-resistant mutants in Mycobacterium smegmatis.
    Mizuguchi Y, Suga K, Masuda K, Yamada T.
    Jpn J Microbiol; 1974 Nov; 18(6):457-62. PubMed ID: 4141739
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A, Mase M, Yamamoto M, Nakamura H.
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract] [Full Text] [Related]

  • 17. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M, Toyama H, Mizuno S, Tsukamura S.
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract] [Full Text] [Related]

  • 18. Altered ribosomes in antibiotic-resistant mutants of Mycobacterium smegmatis.
    Yamada T, Masuda K, Mizuguchi Y, Suga K.
    Antimicrob Agents Chemother; 1976 May; 9(5):817-23. PubMed ID: 182073
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE, Plikaytis BB, Shinnick TM.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T, Minami Y, Maekawa Y, Oi Y.
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.